Recently, a thrombotic thrombocytopenic disorder was observed in 9 patients with monoclonal gammopathy of undetermined significance (MGUS), associated with platelet-activating monoclonal anti-platelet factor 4 (PF4) antibodies [70,71,72,73,74]. This evidence concerns the gene PF4 and monoclonal gammopathy.